Warning! GuruFocus detected
2 Severe warning signs
with CAH.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Cardinal Health Inc
NAICS : 424210
SIC : 5122
ISIN : ARDEUT110798
Share Class Description:
BUE:CAH: CedearCompare
Compare
Traded in other countries / regions
CAH.USACAH.Mexico0HTG.UKCAH.ArgentinaCLH.GermanyC1AH34.Brazil IPO Date
2011-04-26Description
Cardinal Health is one of three leading pharmaceutical wholesalers in the us, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the us pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.5 | |||||
| Equity-to-Asset | -0.06 | |||||
| Debt-to-Equity | -2.54 | |||||
| Debt-to-EBITDA | 2.9 | |||||
| Interest Coverage | 22.96 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.28 | |||||
| Beneish M-Score | -2.16 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.4 | |||||
| 3-Year EBITDA Growth Rate | 22 | |||||
| 3-Year EPS without NRI Growth Rate | 10.6 | |||||
| 3-Year FCF Growth Rate | 24 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 9.87 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.06 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 91.78 | |||||
| 9-Day RSI | 87.38 | |||||
| 14-Day RSI | 83.35 | |||||
| 3-1 Month Momentum % | 10.41 | |||||
| 6-1 Month Momentum % | 15.44 | |||||
| 12-1 Month Momentum % | 28.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.02 | |||||
| Quick Ratio | 0.54 | |||||
| Cash Ratio | 0.11 | |||||
| Days Inventory | 28.32 | |||||
| Days Sales Outstanding | 19.58 | |||||
| Days Payable | 54.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.09 | |||||
| Dividend Payout Ratio | 0.03 | |||||
| 3-Year Dividend Growth Rate | 1 | |||||
| Forward Dividend Yield % | 1.2 | |||||
| 5-Year Yield-on-Cost % | 1.15 | |||||
| 3-Year Average Share Buyback Ratio | 5.7 | |||||
| Shareholder Yield % | -1.04 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 3.44 | |||||
| Operating Margin % | 0.99 | |||||
| Net Margin % | 0.59 | |||||
| FCF Margin % | -0.28 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 2.88 | |||||
| ROIC % | 14.69 | |||||
| 3-Year ROIIC % | 50.74 | |||||
| ROC (Joel Greenblatt) % | 75.17 | |||||
| ROCE % | 19.84 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.46 | |||||
| Forward PE Ratio | 2.05 | |||||
| PE Ratio without NRI | 17.65 | |||||
| Shiller PE Ratio | 118.23 | |||||
| PS Ratio | 0.15 | |||||
| EV-to-EBIT | 19.54 | |||||
| EV-to-Forward-EBIT | 13.82 | |||||
| EV-to-EBITDA | 14.04 | |||||
| EV-to-Forward-EBITDA | 10.72 | |||||
| EV-to-Revenue | 0.17 | |||||
| EV-to-Forward-Revenue | 0.15 | |||||
| EV-to-FCF | -75.77 | |||||
| Price-to-GF-Value | 1.32 | |||||
| Price-to-Projected-FCF | 1.63 | |||||
| Price-to-Median-PS-Value | 1.27 | |||||
| Earnings Yield (Greenblatt) % | 5.12 | |||||
| FCF Yield % | -1.47 | |||||
| Forward Rate of Return (Yacktman) % | 1.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cardinal Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ARS) | 205,236,958.395 | ||
| EPS (TTM) (ARS) | 15079.965 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 2.45 | ||
| 3-Year Sortino Ratio | 9.32 | ||
| Volatility % | 24.68 | ||
| 14-Day RSI | 83.35 | ||
| 14-Day ATR (ARS) | 792.45478 | ||
| 20-Day SMA (ARS) | 54297.5 | ||
| 12-1 Month Momentum % | 28.08 | ||
| 52-Week Range (ARS) | 34789 - 59550 | ||
| Shares Outstanding (Mil) | 80.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cardinal Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cardinal Health Inc Stock Events
| Event | Date | Price (ARS) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cardinal Health Inc Frequently Asked Questions
What is Cardinal Health Inc(BUE:CAH)'s stock price today?
The current price of BUE:CAH is ARS59450.00. The 52 week high of BUE:CAH is ARS59550.00 and 52 week low is ARS34789.00.
When is next earnings date of Cardinal Health Inc(BUE:CAH)?
The next earnings date of Cardinal Health Inc(BUE:CAH) is 2025-05-01.
Does Cardinal Health Inc(BUE:CAH) pay dividends? If so, how much?
The Dividend Yield %  of Cardinal Health Inc(BUE:CAH) is 1.09% (As of Today), Highest Dividend Payout Ratio of Cardinal Health Inc(BUE:CAH) was 0.39. The lowest was 0.03. And the median was 0.35. The  Forward Dividend Yield % of Cardinal Health Inc(BUE:CAH) is 1.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers